HCW Biologics Inc. - 8-K Filing
HCW Biologics Inc. received a notice from Nasdaq on March 26, 2026, stating its stock failed to maintain the minimum bid price of $1 per share for continued listing under Rule 5550(a)(2). On May 29, 2026, Nasdaq granted an extension until July 29, 2026, allowing HCW Biologics Inc. to regain compliance by achieving a minimum bid price of $1 per share for twenty consecutive trading days. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)
Tickers: $HCWB